Interpatient Pharmacokinetic and Pharmacodynamic Variability of Carrier-Mediated Anticancer Agents

The evaluation of gender on the pharmacokinetics (PK) of pegylated liposomal anticancer agents.

(2017) N. M. La-Beck et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of geriatric vulnerability parameters on pegylated liposomal doxorubicin (PLD) tolerance and outcome in elderly patients with metastatic breast cancer: Results of the DOGMES multicenter phase II GINECO trial.

(2017) C. Falandry et al.   JOURNAL OF CLINICAL ONCOLOGY

Synergy of Nab-paclitaxel and Bevacizumab in Eradicating Large Orthotopic Breast Tumors and Preexisting Metastases

(2015) Lisa D. Volk et al.   NEOPLASIA

Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients

(2011) Ninh M. La-Beck et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

(2010) C. Rochlitz et al.   ANNALS OF ONCOLOGY

Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial

(2010) G. P. Stathopoulos et al.   ANNALS OF ONCOLOGY

Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors

(2010) William C. Zamboni et al.   JOURNAL OF LIPOSOME RESEARCH

Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery

(2010) T. D. Tailor et al.   MOLECULAR CANCER THERAPEUTICS

XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer

(2009) Alexander V. Yurkovetskiy et al.   ADVANCED DRUG DELIVERY REVIEWS

Pharmacokinetic Study of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies

(2009) W C Zamboni et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Nanoparticle therapeutics: a personal perspective

(2009) Scott E. McNeil   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology

Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development

(2008) Daryl C. Drummond et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Pharmacokinetics and Biodistribution of Nanoparticles

(2008) Shyh-Dar Li et al.   MOLECULAR PHARMACEUTICS

Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle Biodistribution

(2008) Marina A. Dobrovolskaia et al.   MOLECULAR PHARMACEUTICS

Concept and Clinical Evaluation of Carrier-Mediated Anticancer Agents

(2008) W. C. Zamboni   ONCOLOGIST